000 | 01664 a2200505 4500 | ||
---|---|---|---|
005 | 20250518060109.0 | ||
264 | 0 | _c20200401 | |
008 | 202004s 0 0 eng d | ||
022 | _a2047-4849 | ||
024 | 7 |
_a10.1039/c9bm01017c _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiu, Shuwei | |
245 | 0 | 0 |
_aMultidrug resistant tumors-aimed theranostics on the basis of strong electrostatic attraction between resistant cells and nanomaterials. _h[electronic resource] |
260 |
_bBiomaterials science _cDec 2019 |
||
300 |
_a4990-5001 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aDrug Resistance, Multiple _xdrug effects |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIron _xchemistry |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMouth Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
650 | 0 | 4 | _aStatic Electricity |
650 | 0 | 4 | _aTheranostic Nanomedicine |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVincristine _xadministration & dosage |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aWang, Lu | |
700 | 1 | _aLi, Shuyao | |
700 | 1 | _aMeng, Xuya | |
700 | 1 | _aSun, Bin | |
700 | 1 | _aZhang, Xue | |
700 | 1 | _aZhang, Lening | |
700 | 1 | _aLiu, Yi | |
700 | 1 | _aLin, Min | |
700 | 1 | _aZhang, Hao | |
700 | 1 | _aYang, Bai | |
773 | 0 |
_tBiomaterials science _gvol. 7 _gno. 12 _gp. 4990-5001 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1039/c9bm01017c _zAvailable from publisher's website |
999 |
_c30074476 _d30074476 |